📚 A-Level Biology: Applications of Gene Technology in Medical Diagnosis and Treatment | A-Level 生物：基因技术在医学诊断治疗中的应用
Gene technology has transformed modern medicine by enabling precise detection of genetic disorders, production of therapeutic proteins, and development of novel treatments such as gene therapy and gene editing. This article covers the key applications required for CIE A-Level Biology, with emphasis on diagnostic tools and therapeutic strategies.
基因技术通过精确检测遗传病、生产治疗性蛋白质以及开发基因治疗和基因编辑等新型疗法，彻底改变了现代医学。本文涵盖CIE A-Level生物考纲中的关键应用，重点介绍诊断工具和治疗策略。
1. Overview of Gene Technology in Medicine | 基因技术医学应用概述
Gene technology in medicine involves the manipulation of nucleic acids (DNA and RNA) for diagnostic, prophylactic, or therapeutic purposes. Common techniques include DNA extraction, PCR, gel electrophoresis, DNA sequencing, and gene transfer. These tools allow doctors to identify mutations, quantify gene expression, and introduce functional genes into patients’ cells.
医学中的基因技术涉及对核酸（DNA和RNA）进行操纵，以达到诊断、预防或治疗的目的。常用技术包括DNA提取、PCR、凝胶电泳、DNA测序和基因转移。这些工具使医生能够识别突变、定量基因表达，并将功能性基因导入患者细胞中。
Medical applications fall into two broad categories: diagnostics (detecting disease-causing alleles or pathogens) and therapeutics (correcting genetic defects, producing drugs, or generating immune responses). Both categories depend on the same fundamental principles of molecular biology, such as complementary base pairing and enzyme-mediated DNA synthesis.
医学应用大致分为两类：诊断（检测致病等位基因或病原体）和治疗（纠正遗传缺陷、生产药物或引发免疫反应）。这两类都依赖于分子生物学的基本原理，如互补碱基配对和酶介导的DNA合成。
2. Gene Probes and DNA Microarrays for Diagnosis | 基因探针与DNA微阵列在诊断中的应用
A gene probe is a short, single-stranded DNA or RNA fragment that is complementary to a specific target sequence. It is labelled with a radioactive or fluorescent marker, allowing hybridisation to be detected. In medical diagnosis, probes can identify the presence of a mutant allele, a pathogen’s genome, or a gene associated with cancer.
基因探针是一段与特定靶序列互补的短单链DNA或RNA片段。它带有放射性或荧光标记，从而可以检测杂交结果。在医学诊断中，探针可用于检测突变等位基因的存在、病原体基因组或与癌症相关的基因。
DNA microarrays (gene chips) contain thousands of different probes fixed to a solid surface. A patient’s DNA or RNA is applied to the chip; complementary sequences bind to specific spots, producing a signal. This technique allows simultaneous screening of many genetic variants, such as BRCA1/BRCA2 mutations in breast cancer, or the expression profile of tumour suppressor genes.
DNA微阵列（基因芯片）将数千种不同探针固定在固体表面上。将患者的DNA或RNA加到芯片上；互补序列与特定位点结合并产生信号。该技术可同时筛查许多遗传变异，例如乳腺癌中的BRCA1/BRCA2突变，或肿瘤抑制基因的表达谱。
3. Polymerase Chain Reaction in Diagnosis | 聚合酶链式反应在诊断中的应用
The polymerase chain reaction (PCR) amplifies a specific DNA region exponentially. Each cycle involves denaturation (heating to ~95°C to separate strands), annealing (~50-65°C for primers to bind), and extension (~72°C for thermostable Taq polymerase to synthesise new DNA). PCR generates millions of copies from a tiny sample, enabling detection of trace amounts of viral or bacterial DNA.
聚合酶链式反应（PCR）可指数级扩增特定DNA区域。每个循环包括变性（加热至约95°C使双链分离）、退火（约50-65°C让引物结合）和延伸（约72°C由耐热的Taq聚合酶合成新DNA）。PCR能从极少量样本中产生数百万个拷贝，从而检测痕量的病毒或细菌DNA。
PCR is essential in diagnosing infectious diseases such as HIV and tuberculosis, where early detection is critical. It is also used to detect genetic mutations in prenatal samples and in forensic medicine to match DNA from crime scenes. Real-time PCR (qPCR) quantifies the amount of starting DNA, which is useful for monitoring viral load during therapy.
PCR对于诊断HIV和肺结核等传染病至关重要，因为早期检测十分关键。它也用于产前样本的基因突变检测，以及法医学中比对犯罪现场的DNA。实时定量PCR（qPCR）可定量初始DNA量，有助于治疗期间监测病毒载量。
4. Gel Electrophoresis and Southern Blotting | 凝胶电泳与Southern印迹法
Gel electrophoresis separates DNA fragments by size when an electric current is applied through an agarose gel. Because DNA is negatively charged, fragments move towards the positive electrode; smaller fragments travel faster, producing distinct bands. This technique is used to verify PCR products and to analyse restriction enzyme digests.
凝胶电泳在琼脂糖凝胶中施加电流，按DNA片段大小将其分离。由于DNA带负电荷，片段向正极移动；较小的片段移动更快，形成明显条带。该技术用于验证PCR产物和分析限制性酶切产物。
Southern blotting combines gel electrophoresis with hybridisation. DNA is transferred to a nitrocellulose membrane and incubated with a labelled probe. This method detects specific sequences within complex genomes, such as the sickle-cell allele (β-globin gene mutation) or deletion mutations in Duchenne muscular dystrophy. Southern blotting remains a reliable confirmatory test for many inherited disorders.
Southern印迹法将凝胶电泳与杂交结合。DNA被转移到硝酸纤维素膜上，并与标记探针孵育。该方法可在复杂基因组中检测特定序列，如镰刀型细胞贫血等位基因（β-珠蛋白基因突变）或杜氏肌营养不良中的缺失突变。Southern印迹法仍是许多遗传病可靠的确认性检测方法。
5. DNA Sequencing and Genomic Analysis | DNA测序与基因组分析
DNA sequencing determines the exact order of nucleotides in a DNA fragment. The Sanger (chain-termination) method uses modified nucleotides that halt DNA synthesis, producing fragments of different lengths that are separated by electrophoresis. Next-generation sequencing (NGS) enables rapid, low-cost sequencing of whole genomes, making it a powerful tool for diagnosing rare genetic diseases.
DNA测序确定DNA片段中核苷酸的精确顺序。桑格（链终止）法使用修饰核苷酸终止DNA合成，产生不同长度的片段并经电泳分离。下一代测序（NGS）能够快速、低成本地测序全基因组，使其成为诊断罕见遗传病的强力工具。
Whole-genome sequencing can identify pathogenic mutations in cancer cells, guiding targeted therapy. For example, mutations in the EGFR gene in lung cancer determine whether a patient will respond to specific tyrosine kinase inhibitors. Gene expression profiling (RNA-seq) also helps classify tumours and predict prognosis.
全基因组测序可以识别癌细胞中的致病突变，指导靶向治疗。例如，肺癌中EGFR基因突变可判断患者是否对特定的酪氨酸激酶抑制剂有反应。基因表达谱分析（RNA-seq）也有助于肿瘤分类和预后预测。
6. Gene Therapy: Principles and Delivery | 基因治疗：原理与递送方式
Gene therapy aims to correct a defective gene by introducing a functional copy into target cells. This can be achieved in vivo (directly delivering the gene into the patient) or ex vivo (removing cells, modifying them in the laboratory, and transplanting them back). Delivery vectors include modified viruses, such as retroviruses or adenoviruses, which insert the therapeutic gene into host cells.
基因治疗旨在通过将功能基因导入靶细胞来纠正有缺陷的基因。可以通过体内方式（直接将基因递送到患者体内）或体外方式（取出细胞、在实验室中修饰后植回患者体内）实现。递送载体包括经修饰的病毒，如逆转录病毒或腺病毒，它们将治疗基因插入宿主细胞。
A classic example is the treatment of severe combined immunodeficiency (SCID) caused by adenosine deaminase deficiency. T cells from the patient are corrected ex vivo and reintroduced, restoring immune function. However, gene therapy carries risks: viral vectors may integrate near oncogenes, causing leukaemia, or provoke severe immune responses. Somatic gene therapy affects only the patient, whereas germ-line gene therapy (currently banned ethically) would alter future generations.
一个经典例子是治疗由腺苷脱氨酶缺乏引起的重症联合免疫缺陷（SCID）。从患者体内取出T细胞，在体外进行基因修正后重新注入，从而恢复免疫功能。然而，基因治疗存在风险：病毒载体可能整合到癌基因附近导致白血病，或引发严重的免疫反应。体细胞基因治疗只影响患者本人，而生殖系基因治疗（目前被伦理禁止）将改变后代。
7. CRISPR-Cas9 and Genome Editing | CRISPR-Cas9与基因组编辑
CRISPR-Cas9 is a precise genome-editing tool derived from bacterial defence systems. A guide RNA (gRNA) directs the Cas9 nuclease to a specific DNA sequence, where it creates a double-strand break. The cell repairs the break either by error-prone non-homologous end joining (NHEJ), which can disrupt a gene, or by homology-directed repair (HDR), which can insert a correct sequence.
CRISPR-Cas9是一种源自细菌防御系统的精确基因组编辑工具。向导RNA（gRNA）将Cas9核酸酶引导至特定DNA序列，使其产生双链断裂。细胞通过容易出错的非同源末端连接（NHEJ）修复断裂，从而可能破坏基因；或者通过同源定向修复（HDR）插入正确序列。
This technology has already entered clinical trials for conditions such as sickle-cell disease and beta-thalassaemia. In these trials, haematopoietic stem cells are edited ex vivo to reactivate fetal haemoglobin production, then returned to the patient. CRISPR also offers hope for treating cystic fibrosis by correcting the CFTR mutation in airway epithelial cells. Challenges include off-target effects and ethical concerns about editing embryos.
该技术已进入镰刀型细胞贫血和β-地中海贫血等疾病的临床试验。在这些试验中，造血干细胞在体外被编辑以重新激活胎儿血红蛋白生成，然后回输给患者。CRISPR还为治疗囊性纤维化提供了希望，通过校正气道上皮细胞中的CFTR突变。挑战包括脱靶效应以及编辑胚胎的伦理问题。
8. Production of Therapeutic Proteins Using Gene Technology | 基因工程技术生产治疗性蛋白质
Recombinant DNA technology allows human genes to be inserted into host cells such as bacteria, yeast, or mammalian cells, which then produce therapeutic proteins. Human insulin was the first recombinant protein approved for medical use. The insulin gene is inserted into a plasmid vector, the vector is transformed into E. coli, and the bacteria are cultured in fermenters to synthesise insulin.
重组DNA技术允许将人类基因插入宿主细胞（如细菌、酵母或哺乳动物细胞）中，进而生产治疗性蛋白质。人胰岛素是首个获准用于医疗的重组蛋白。将胰岛素基因插入质粒载体，转化到大肠杆菌中，然后在发酵罐中培养细菌以合成胰岛素。
Recombinant technology avoids the risk of contamination from animal sources and provides a limitless supply of human-identical proteins. Other examples include human growth hormone (used to treat dwarfism), clotting factor VIII (for haemophilia), and tissue plasminogen activator (for heart attacks). Glycosylation differences mean that many complex proteins must be made in mammalian cells, which is more costly.
重组技术避免了动物来源的污染风险，并提供无限量的人源相同蛋白质供应。其他例子包括人生长激素（治疗侏儒症）、凝血因子VIII（用于血友病）和组织型纤溶酶原激活剂（用于心脏病发作）。由于糖基化差异，许多复杂蛋白质必须在哺乳动物细胞中生产，成本更高。
9. Gene Vaccines and Immunotherapy | 基因疫苗与免疫治疗
DNA vaccines consist of a plasmid carrying a gene that encodes a pathogen antigen. When injected into muscle cells, the cells express the antigen and display it on their surface, triggering both humoral and cell-mediated immune responses. This approach mimics a natural viral infection without causing disease, and it stimulates cytotoxic T cells more effectively than traditional protein vaccines.
DNA疫苗由携带编码病原体抗原基因的质粒组成。当注射到肌肉细胞中时，细胞表达抗原并呈递在细胞表面，引发体液免疫和细胞介导免疫反应。这种方法模拟自然病毒感染而不致病，并且比传统蛋白疫苗更有效地刺激细胞毒性T细胞。
Gene – based vaccines played a major role in the COVID – 19 pandemic: mRNA vaccines instruct cells to produce the spike protein, eliciting protective antibodies. Advantages of gene vaccines include rapid development, easy large-scale production, and the ability to modify the antigen sequence quickly when new variants emerge. They are also being researched for cancer immunotherapy, where plasmids encode tumour antigens to stimulate the immune system to attack cancer cells.
基因疫苗在COVID-19大流行中发挥了重要作用：mRNA疫苗指导细胞产生刺突蛋白，引发保护性抗体。基因疫苗的优点是开发迅速、易于大规模生产，并且在新变异出现时能快速修改抗原序列。它们也被研究用于癌症免疫治疗，通过质粒编码肿瘤抗原来刺激免疫系统攻击癌细胞。
10. Prenatal Diagnosis and Genetic Screening | 产前诊断与遗传筛查
Prenatal genetic diagnosis involves testing foetal cells obtained by amniocentesis (sampling amniotic fluid at around 15 weeks) or chorionic villus sampling (CVS at around 10-12 weeks). The extracted DNA can be analysed by PCR, sequencing, or microarray to detect chromosomal abnormalities such as Down syndrome (trisomy 21) and single-gene disorders like cystic fibrosis or Huntington’s disease.
产前基因诊断涉及检测通过羊膜穿刺术（约15周时抽取羊水）或绒毛取样（CVS约10-12周）获得的胎儿细胞。提取的DNA可通过PCR、测序或微阵列分析，检测染色体异常如唐氏综合征（21三体），以及囊性纤维化或亨廷顿病等单基因疾病。
Genetic screening allows couples with a family history of inherited disorders to make informed reproductive decisions. Preimplantation genetic diagnosis (PGD) is performed on embryos created by IVF before implantation, selecting only healthy embryos. These technologies raise ethical issues regarding selective abortion, disability rights, and the potential for eugenic choices.
遗传筛查使有遗传病家族史的夫妇能够做出知情的生育决定。植入前遗传学诊断（PGD）在体外受精胚胎植入前进行检测，仅选择健康胚胎。这些技术引发了关于选择性流产、残疾人权利以及优生学选择的伦理问题。
11. Pharmacogenomics and Personalised Medicine | 药物基因组学与个性化医疗
Pharmacogenomics is the study of how an individual’s genetic makeup affects their response to drugs. Genetic variations, such as single nucleotide polymorphisms (SNPs), can alter drug-metabolising enzymes, drug transporters, or drug targets. For example, variants in the CYP2C9 and VKORC1 genes influence the metabolism of warfarin, an anticoagulant with a narrow therapeutic window.
药物基因组学研究个体基因组成如何影响其对药物的反应。单核苷酸多态性（SNPs）等遗传变异可改变药物代谢酶、药物转运蛋白或药物靶点。例如，CYP2C9和VKORC1基因的变异影响抗凝药华法林的代谢，该药的安全治疗窗口很窄。
By testing a patient’s genotype before prescribing, doctors can choose the correct drug and dosage, reducing adverse effects and improving efficacy. Examples include testing for HLA-B*5701 before abacavir prescription in HIV therapy to prevent hypersensitivity, and using TPMT gene testing to guide thiopurine dosing in leukaemia. Personalised medicine promises safer, more effective treatments tailored to each patient’s genetic profile.
通过开药前检测患者的基因型，医生可以选择正确的药物和剂量，减少不良反应并提高疗效。例如，在HIV治疗中开阿巴卡韦前检测HLA-B*5701以避免过敏反应；在白血病中使用TPMT基因检测指导硫嘌呤剂量。个性化医疗有望根据每位患者的基因特征提供更安全、更有效的治疗。
12. Ethical Considerations and Future Directions | 伦理问题与未来展望
The rapid expansion of gene technology brings unresolved ethical issues. Privacy of genetic information must be protected; employers or insurers may misuse genetic data to discriminate against individuals. The use of gene editing in human embryos is highly controversial, as changes would be heritable and could be used for non-therapeutic enhancement, such as selecting for intelligence or physical traits.
基因技术的迅速扩展带来了尚未解决的伦理问题。遗传信息的隐私必须受到保护；雇主或保险公司可能滥用基因数据进行歧视。使用基因编辑修饰人类胚胎极具争议，因为这些改变是可遗传的，并且可能被用于非治疗性的增强，如选择智力或身体特征。
Future directions include improving the safety and accuracy of CRISPR delivery, developing multi-gene therapies for complex diseases like cancer and cardiovascular disorders, and integrating genomic data with electronic health records for routine preventive medicine. Education and regulation will be essential to ensure that gene technology is used responsibly and equitably.
未来方向包括提高CRISPR递送的安全性和准确性，开发针对癌症和心血管疾病等复杂疾病的多基因疗法，以及将基因组数据与电子健康记录整合用于常规预防医学。教育和监管对于确保基因技术负责任且公平地使用至关重要。
Published by TutorHao | Biology Revision Series | aleveler.com
更多咨询请联系16621398022（同微信）
屏轩国际教育cambridge primary/secondary checkpoint, cat4, ukiset,ukcat,igcse,alevel,PAT,STEP,MAT, ibdp,ap,ssat,sat,sat2课程辅导，国外大学本科硕士研究生博士课程论文辅导